Nem Laboratories (P) Ltd. (NemLabs) is an established pharmaceutical company with nearly four decades of experience in developing and manufacturing finished pharmaceutical products. Trusted by healthcare partners across 36 countries, our portfolio includes tablets, sterile and non-sterile creams, ointments and gels, and small-volume injectables. Our end-to-end capabilities span formulation development, regulatory support and scalable commercial manufacturing. Supported by a DSIR-recognized R&D centre, more than 75 CTD/eCTD dossiers, advanced manufacturing technologies and intelligent automation, we deliver reliable, effective and affordable generic medicines with a strong focus on quality, regulatory compliance and patient outcome
"Health First" is a promise.
A promise to deliver uncompromising quality in every product we manufacture and every service we provide. Every decision we make is guided by our responsibility to improve lives, earn the trust of our people and contribute to a healthier future for communities around the world.
Our diverse portfolio of trusted pharmaceutical brands reflects our commitment to quality, innovation, and better patient outcomes. We offer a comprehensive range of products across multiple therapeutic segments, developed to meet the evolving needs of healthcare professionals and patients.
Our state-of-the-art facilities are designed for versatile production across multiple dosage forms, ensuring scalability and consistency.
Our formulations serve patients across Latin America, Africa, CIS countries, SE Asia, and India. This global footprint is a testament to our commitment to making high-quality healthcare accessible.